Retraction: Trop2 promotes proliferation, invasion and EMT of nasopharyngeal carcinoma cells through the NF-κB pathway

Nan Cheng; Haixia Li; Junpeng Luo

doi:10.1039/D2RA90019J

View PDF VersionPrevious ArticleNext Article

Open Access Article

This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

DOI: 10.1039/D2RA90019J (Retraction) RSC Adv., 2022, 12, 6906-6906

Retraction: Trop2 promotes proliferation, invasion and EMT of nasopharyngeal carcinoma cells through the NF-κB pathway

Nan Cheng ^a, Haixia Li ^a and Junpeng Luo *^b
^aDepartment of Otolaryngological, Huaihe Hospital of Henan University, Kaifeng, 475000, China
^bDepartment of Oncology, Huaihe Hospital of Henan University, No. 8, Baobei Road, Gulou District, Kaifeng, 475000, China. E-mail: pengluoun@163.com; Tel: +86-371-23906055

Received 24th February 2022 , Accepted 24th February 2022

First published on 2nd March 2022

Abstract

Retraction of ‘Trop2 promotes proliferation, invasion and EMT of nasopharyngeal carcinoma cells through the NF-κB pathway’ by Nan Cheng et al., RSC Adv., 2017, 7, 53087–53096, DOI: 10.1039/c7ra09915k.

The authors hereby wholly retract this RSC Advances article due to concerns with the reliability of the data. The authors have attempted to replicate the experiments described in the article but were unable to achieve the same results.

Given the lack of reliable raw data, the authors can no longer guarantee that the findings presented in this paper are accurate.

Signed: Junpeng Luo

Date: 24^th February 2022

Retraction endorsed by Laura Fisher, Executive Editor, RSC Advances